Back to StakeholdersPrimary Platform Link
Kernel
United States
1 Trial
Neurotechnology company developing non-invasive brain measurement systems with applications in psychiatry and published psychedelic-adjacent ketamine research collaborations.
Academic Research
0 papersPublished Papers
0
Trial Involvement
1
Distinct Focus Topics
0
Latest Publication
Unknown
Technology, Data, & Software Snapshot
NeurotechnologyPlatform Model
Neurotechnology Hardware + Software
Deployment
Hardware + Software Bundle
Geography
Global
Coverage
Global
Customer Types
Research OrganizationsDrug Developers
Capability Focus Areas
Neurodata Capture & ProcessingDigital Biomarkers
Data Modalities
NeuroimagingEEG / ECG / Biosignals
Technology Notes
Kernel describes neuroimaging biomarker platform capabilities and reports sponsored ketamine psychedelic work in public updates.
Verification
Verified
Psychedelic Focus
Psychedelic-Adjacent Focus
Engagement Status
Active
Last Verified
Apr 9, 2026
Quick Facts
- Type
- Private Biotech
- HQ
- United States
- Website
- Visit